Biological control program - phase I. DARPA anticipates that the biological control program will provide predictive, closed-loop, generalizable means for controlling various biological systems and…

Ended Definitive Contract Awarded Last action

Contract number
HR001116C0138
Awardee
Awarding agency
Obligated
$2,799,942

Award facts

Opportunity
Contract value 100% obligated
$2,799,942.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 20 offers Basic Research
Pricing
Cost No Fee
Place of performance
Durham, NC 27705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00009 · Biological control program - phase III $616,439
Supplemental Agreement for work within scope P00008 · Biological control program - phase II $0
Funding Only Action P00007 · Biological control program (BIOCON) - phase II $462,242
Exercise an Option P00006 · Biological control program - phase II. The purpose of this rescope modification is to remove attachment 1 - SOW, (revision 1), in its entirety and replace IT… $684,698
Other Administrative Action P00005 · Biological control program - phase I - administrative modification to add option clause far 52.217-7. $0
Supplemental Agreement for work within scope P00004 · Biological control program. The purpose of this modification is to extend the period of performance of phase I (clin 0001) by one month, from april 1, 2018 to… $0
Change Order P00003 $0
Funding Only Action P00002 · Biological control program - phase I. The purpose of this modification is to provide incremental funding in the amount of $691,042 to clin 0001 via subclin… $691,042
Other Administrative Action P00001 · (biological control program - phase I) the purpose of this modificaiton is to correct the wawf table and to incoporate attachment 5 and attachment 6, acuro… $0
Original award $345,521

About this award

This federal contract award with ID HR001116C0138 was issued by the Defense Advanced Research Projects Agency (DARPA) to Duke University, a private research university in Durham, North Carolina. The $2,799,942 definitive contract, which does not utilize a set-aside, is for the Biological Control Program - Phase I. This program aims to provide predictive, closed-loop, and generalizable means for controlling various biological systems and programming diverse system-level behaviors across multiple scales.

The contract involves a subcontract to the California Institute of Technology (Caltech) for experiments requiring a combination of mammalian signaling pathway design, cell line engineering, quantitative analysis of intercellular signaling, and mathematical modeling. Duke University, as the prime contractor, has a strong track record of federal contract and grant awards, particularly in the areas of medical research, engineering, and technology innovation. This contract award is part of DARPA's broader efforts to advance biotechnology and develop novel control mechanisms for biological systems.

Description

Biological control program - phase I. DARPA anticipates that the biological control program will provide predictive, closed-loop, generalizable means for controlling various biological systems and programming diverse system level behaviors across multiple scales.

Quick answers

Who was awarded contract HR001116C0138?

HR001116C0138 was awarded to Duke University by Defense Advanced Research Projects Agency (Department of Defense) on October 1, 2016.

How much is contract HR001116C0138 worth?

The government has obligated $2,799,942 on HR001116C0138.

Was contract HR001116C0138 competed?

The extent of competition for HR001116C0138 was full and open competition. The government received 20 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award